These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17420198)

  • 21. Suppression of antipsychotic-induced tardive dyskinesia with aripiprazole in an elderly patient with bipolar I disorder.
    Wu WY; Chan HY; Tan HK
    Acta Neuropsychiatr; 2014 Feb; 26(1):61-4. PubMed ID: 25142102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aripiprazole and extrapyramidal symptoms.
    Lindsey RL; Kaplan D; Koliatsos V; Walters JK; Sandson NB
    J Am Acad Child Adolesc Psychiatry; 2003 Nov; 42(11):1268-9. PubMed ID: 14566162
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral aripiprazole-induced severe hypoglycemia.
    Mondal S; Saha I; Das S; Ganguly A; Ghosh A; Kumar Das A
    Ther Drug Monit; 2012 Jun; 34(3):245-8. PubMed ID: 22549500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia.
    McEvoy JP; Daniel DG; Carson WH; McQuade RD; Marcus RN
    J Psychiatr Res; 2007 Dec; 41(11):895-905. PubMed ID: 17631314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proposed strategies for successful clinical management with aripiprazole.
    Mago R
    Expert Opin Pharmacother; 2008 Jun; 9(8):1279-90. PubMed ID: 18473703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of Aripiprazole and extra pyramidal side effects.
    Salmoiraghi A; Odiyoor M
    J Psychopharmacol; 2006 Jul; 20(4):592-3. PubMed ID: 16401661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Torsades de pointes after administration of low-dose aripiprazole.
    Nelson S; Leung JG
    Ann Pharmacother; 2013 Feb; 47(2):e11. PubMed ID: 23362038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case series: extrapyramidal symptoms associated with use of aripiprazole in older adults.
    Sweeney EB; Lawlor BA
    Int J Geriatr Psychiatry; 2013 Nov; 28(11):1208-10. PubMed ID: 24101361
    [No Abstract]   [Full Text] [Related]  

  • 30. Oculogyric crisis: a rare extrapyramidal side effect in the treatment of Tourette syndrome.
    Rizzo R; Gulisano M; Calì PV
    Eur Child Adolesc Psychiatry; 2012 Oct; 21(10):591-2. PubMed ID: 22692815
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the safety and tolerability of aripiprazole.
    Pae CU
    Expert Opin Drug Saf; 2009 May; 8(3):373-86. PubMed ID: 19505266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute dystonia with low-dosage aripiprazole in Tourette's disorder.
    Fountoulakis KN; Siamouli M; Kantartzis S; Panagiotidis P; Iacovides A; Kaprinis GS
    Ann Pharmacother; 2006 Apr; 40(4):775-7. PubMed ID: 16569800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aripiprazole induced non-cardiogenic pulmonary edema: a case report.
    Cetin M; Celik M; Cakıcı M; Polat M; Suner A
    Turk Psikiyatri Derg; 2014; 25(4):287-9. PubMed ID: 25487626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased aripiprazole concentrations in an HIV-positive male concurrently taking duloxetine, darunavir, and ritonavir.
    Aung GL; O'Brien JG; Tien PG; Kawamoto LS
    Ann Pharmacother; 2010 Nov; 44(11):1850-4. PubMed ID: 20978219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patient.
    Patel MK; Brunetti L
    Am J Health Syst Pharm; 2010 Aug; 67(15):1254-9. PubMed ID: 20651315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: a case series.
    Shastri M; Alla L; Sabaratnam M
    J Psychopharmacol; 2006 Nov; 20(6):863-7. PubMed ID: 16891339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tardive dyskinesia due to aripiprazole: report of 2 cases.
    Lungu C; Aia PG; Shih LC; Esper CD; Factor SA; Tarsy D
    J Clin Psychopharmacol; 2009 Apr; 29(2):185-6. PubMed ID: 19512985
    [No Abstract]   [Full Text] [Related]  

  • 39. No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.
    Park CH; Park TW; Yang JC; Lee KH; Huang GB; Tong Z; Park MS; Chung YC
    Int Clin Psychopharmacol; 2012 Mar; 27(2):114-20. PubMed ID: 22241281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study.
    Meco G; Stirpe P; Edito F; Purcaro C; Valente M; Bernardi S; Vanacore N
    J Neural Transm (Vienna); 2009 Jul; 116(7):881-4. PubMed ID: 19533295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.